Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$58.53 - $68.82 $2,809 - $3,303
48 Added 3.12%
1,585 $101,000
Q1 2024

May 06, 2024

BUY
$54.2 - $69.69 $83,305 - $107,113
1,537 New
1,537 $106,000
Q1 2023

Apr 28, 2023

BUY
$37.61 - $45.72 $106,812 - $129,844
2,840 Added 70.91%
6,845 $272,000
Q4 2022

Feb 02, 2023

BUY
$31.9 - $41.95 $127,759 - $168,009
4,005 New
4,005 $161,000
Q2 2022

Jul 29, 2022

SELL
$23.09 - $33.46 $55,046 - $79,768
-2,384 Reduced 29.57%
5,677 $168,000
Q1 2022

Apr 29, 2022

SELL
$26.91 - $47.15 $102,634 - $179,830
-3,814 Reduced 32.12%
8,061 $227,000
Q4 2021

Feb 07, 2022

SELL
$32.97 - $56.85 $24,694 - $42,580
-749 Reduced 5.93%
11,875 $547,000
Q3 2021

Nov 01, 2021

BUY
$26.48 - $35.99 $334,283 - $454,337
12,624 New
12,624 $414,000
Q1 2021

May 13, 2021

SELL
$28.4 - $36.14 $154,552 - $196,673
-5,442 Closed
0 $0
Q4 2020

Feb 04, 2021

SELL
$23.69 - $31.47 $19,520 - $25,931
-824 Reduced 13.15%
5,442 $158,000
Q3 2020

Nov 09, 2020

BUY
$26.38 - $33.1 $165,297 - $207,404
6,266 New
6,266 $177,000
Q2 2020

Jul 20, 2020

SELL
$29.93 - $50.1 $638,646 - $1.07 Million
-21,338 Closed
0 $0
Q1 2020

Apr 30, 2020

BUY
$30.35 - $67.14 $595,770 - $1.32 Million
19,630 Added 1149.3%
21,338 $869,000
Q4 2019

Jan 28, 2020

SELL
$55.65 - $79.83 $1.6 Million - $2.3 Million
-28,836 Reduced 94.41%
1,708 $105,000
Q3 2019

Nov 04, 2019

BUY
$64.7 - $85.39 $1.41 Million - $1.86 Million
21,773 Added 248.24%
30,544 $2.23 Million
Q2 2019

Jul 29, 2019

SELL
$67.77 - $82.2 $4.01 Million - $4.86 Million
-59,133 Reduced 87.08%
8,771 $721,000
Q1 2019

Apr 29, 2019

BUY
$45.83 - $70.54 $2.96 Million - $4.56 Million
64,598 Added 1953.96%
67,904 $4.79 Million
Q4 2018

Feb 01, 2019

SELL
$41.17 - $56.44 $206,467 - $283,046
-5,015 Reduced 60.27%
3,306 $149,000
Q3 2018

Nov 06, 2018

SELL
$52.95 - $71.34 $147,995 - $199,395
-2,795 Reduced 25.14%
8,321 $470,000
Q2 2018

Aug 07, 2018

BUY
$56.38 - $68.08 $293,063 - $353,879
5,198 Added 87.83%
11,116 $743,000
Q1 2018

May 03, 2018

BUY
$56.98 - $72.41 $62,848 - $79,868
1,103 Added 22.91%
5,918 $345,000
Q4 2017

Jan 24, 2018

BUY
$53.3 - $74.56 $56,498 - $79,033
1,060 Added 28.23%
4,815 $310,000
Q3 2017

Nov 07, 2017

BUY
$43.46 - $52.49 $163,192 - $197,099
3,755
3,755 $197,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.